直接口服抗凝药与阿司匹林用于骨科手术后静脉血栓栓塞预防的比较
单中心回顾性研究纳入2011至2015年接受大型骨科手术的420例患者,比较DOAC与阿司匹林在出血和血栓复合终点上的差异。两组复合主要终点比例相似(12.9% vs 13.3%,p>0.5),DOAC组VTE事件数值上更低但无统计学意义,而DOAC组术后输血至少2单位的比例更高(p=0.04)。结论认为两种策略的净临床结局无差异。
要点
- DOAC与阿司匹林在骨科术后VTE预防的净临床结局无显著差异。
- DOAC组VTE事件数值更低但未达统计学意义。
- DOAC组术后输血至少2单位的比例显著高于阿司匹林组。
核心结论
- 大型骨科手术后使用DOAC或阿司匹林进行VTE预防,净临床结局无差异。
研究设计与样本
- 单中心回顾性研究,纳入2011至2015年接受大型骨科手术的患者共420例。
- 主要终点采用调整logistic回归模型分析,倾向性评分作为独立变量纳入。
主要发现
- DOAC组与阿司匹林组复合主要终点比例分别为12.9%和13.3%(p>0.5)。
- DOAC组VTE事件数值上低于阿司匹林组,但差异无统计学意义。
- 两组因VTE或出血再入院率及出血事件相似。
- DOAC组术后输血至少2单位的比例高于阿司匹林组(p=0.04)。
临床怎么用
- 骨科术后VTE预防选择DOAC或阿司匹林时,需权衡血栓与出血风险,净临床结局相似。
- DOAC组术后输血需求更高,临床应关注术后出血风险及输血管理。
局限性
- 单中心回顾性设计可能引入选择偏倚和混杂因素。
- 样本量有限,VTE事件差异未达统计学意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The risks of venous thromboembolism (VTE) and bleeding with direct oral anticoagulants (DOACs) and aspirin for thromboprophylaxis after orthopedic surgery were studied. METHODS: A single center, retrospective study was conducted to examine patients who underwent a major orthopedic surgery from 2011 to 2015. The primary endpoint evaluated was the net clinical outcome of bleeding and thrombosis rates between the DOAC and aspirin groups. Secondary endpoints included bleeding rates, thrombosis rates, transfusion rates, and 90-day readmission rates. The primary endpoint was analyzed using adjusted logistic regression model with propensity score added as an independent variable. RESULTS: A total of 420 patients were included in this study. The proportion of patients with composite primary outcome was similar between the groups (12.9% and 13.3%, in the DOAC and aspirin groups, respectively; p > 0.5). VTE events were numerically lower in the DOAC group, but the result was not statistically significant. Readmission due to VTE or bleeding and bleeding events were also similar between the groups. The DOAC group had a higher proportion of blood transfusions of at least 2 units of blood postoperatively compared with the aspirin group (p = 0.04). CONCLUSION: No difference in net clinical outcome was observed in patients who received a DOAC or aspirin for VTE prophylaxis after major orthopedic surgery.
引用
- Yang T, Murillo M, Vadhariya A, et al. Direct oral anticoagulants versus aspirin for venous thromboembolism prophylaxis after orthopedic surgery. Am J Health Syst Pharm. 2019. PMID: 30994169. doi:10.1093/ajhp/zxy080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。